CNR1 and cancer: A huge spectrum of inducers of acute/de novo cellular ceramide synthesis were discovered in the last three decades for cancer-related therapies, which include but are not limited to stress-induced protein kinase activation, like Fas [2,3,4,5], CB1 [5,6] and CB2 [4].